Neil Tarzy
Family Medicine · Escondido, CANPI 1427030402
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 359 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,834 and has fallen 96.4% since, to $67 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 359 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$837
- Novo Nordisk$743
- GSK$717
- Boehringer Ingelheim$333
- Lilly USA, LLC$327
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,681100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $1,363 |
| AstraZeneca | 44 | $837 |
| Novo Nordisk | 52 | $743 |
| GSK | 45 | $717 |
| Boehringer Ingelheim | 17 | $333 |
| Lilly USA, LLC | 17 | $327 |
| Johnson & Johnson | 14 | $231 |
| Pfizer | 12 | $215 |
| Amarin Pharma, Inc. | 12 | $213 |
| Merck | 12 | $207 |
| Amgen | 10 | $193 |
| Si-bone, Inc. | 2 | $167 |
| Bayer | 6 | $138 |
| Sanofi-aventis U.S. LLC | 8 | $125 |
| Esperion Therapeutics, Inc. | 6 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $86 |
| Boston Scientific | 2 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $63 |
| IBSA Pharma Inc. | 5 | $63 |
| Dexcom, Inc. | 3 | $61 |
| Novartis | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $35 |
| Abbott | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Stryker | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$147
- UBRELVY$124
How this compares
$6,681 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $213 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Escondido
- Jefferson BirchallEscondido$126K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.